Education
About Us
Working with TipRanks
Follow Us
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Oryzon Genomics SA (ORN) Ownership Overview
The ownership structure of Oryzon Genomics SA (DE:ORN) stock is a mix of institutional, retail, and individual investors. , 4.42% is owned by Insiders, and 95.49% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Apr 29, 2025 | xxxxxxxxxxxxx | €50001 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,532,890 | Insider | 4.42% | 13,534,502 | |
| 35,149 | Institution | 0.04% | 134,656 | |
| 35,106 | Institution | 0.04% | 134,491 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 35,106 | Institution | 0.04% | 134,491 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Oryzon Genomics SA (DE:ORN)?
Currently, no data Available
What percentage of Oryzon Genomics SA (DE:ORN) stock is held by institutional investors?
Currently, no data Available
What percentage of Oryzon Genomics SA (DE:ORN) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.49% of Oryzon Genomics SA (DE:ORN) stock is held by retail investors.
Who owns the most shares of Oryzon Genomics SA (DE:ORN)?
Carlos Manuel Buesa Arjol owns the most shares of Oryzon Genomics SA (DE:ORN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.